Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 6

Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease

Authors Mohammed Al-Omran

Published Date January 2007 Volume 2007:3(6) Pages 1019—1027


Published 15 January 2007

Mohammed Al-Omran

Department of Surgery, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

Background: Peripheral arterial disease (PAD) is a marker of advanced atherosclerosis with an elevated risk of cardiovascular mortality and morbidity. Although intensive risk reduction therapy is critical in reducing the adverse cardiovascular outcomes in patients with PAD, the awareness of this information among all physicians is felt to be low. Given the role of family physicians (FP), general internists (GI), cardiologists (C), and vascular surgeons (VS) in treating patients with PAD, we sought to determine their perceptions and knowledge of risk reduction therapy in these patients.

Methods and results: We conducted a cross-sectional self-administered survey of 84 physicians who work at a major teaching hospital. FP, GI, C, and VS represent 39%, 33%, 16%, and 12% of the surveyed physicians, respectively. The recommended targets of LDL-cholesterol, blood glucose and blood pressure in PAD patients were known to 37.3%, 94.1% and 35.3% of physicians, respectively. The majority of physicians reported to screen for risk factors in PAD. Although 86.3% of physicians would recommend antiplatelets therapy in PAD, only 17.6% would recommend angiotensin converting enzyme (ACE) inhibitors; 25.5% would recommend nicotine replacement therapy for smokers and 62.7% would recommend statins. Compared to other specialties, cardiologists had the lowest threshold, whereas GI had the highest threshold for initiating antiplatelets and statins for patients with PAD.

Conclusion: The perceptions towards risk reduction in PAD identify glaring knowledge and action gaps. Effective strategies to encourage health professionals to use risk reduction therapy are needed.
Keywords: peripheral arterial disease, risk reduction, atherosclerosis

Download Article [PDF] 

Readers of this article also read:

Ultrastructural localization of intravenously injected carbon nanohorns in tumor

Matsumura S, Yuge R, Sato S, Tomida A, Ichihashi T, Irie H, Iijima S, Shiba K, Yudasaka M

International Journal of Nanomedicine 2014, 9:3499-3508

Published Date: 23 July 2014

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Nutritional self-care in two older Norwegian males: a case study

Tomstad ST, Söderhamn U, Espnes GA, Söderhamn O

Clinical Interventions in Aging 2013, 8:609-620

Published Date: 31 May 2013

Lived experiences of self-care among older physically active urban-living individuals

Sundsli K, Espnes GA, Söderhamn O

Clinical Interventions in Aging 2013, 8:123-130

Published Date: 30 January 2013

Corneal topographic changes following trans-conjunctival 20 gauge sutureless vitrectomy (TC20V)

Abdel Alim Mohamed A, Abdrabbo M

Clinical Ophthalmology 2012, 6:565-569

Published Date: 24 April 2012

Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study

Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al

Vascular Health and Risk Management 2009, 5:673-676

Published Date: 11 August 2009

The characteristics of keratomycosis by Beauveria bassiana and its successful treatment with antimycotic agents

Hiroko Sonoyama, Kaoru Araki-Sasaki, Shigeyasu Kazama, Tsutomu Kawasaki, Hidenao Ideta, et al

Clinical Ophthalmology 2008, 2:675-678

Published Date: 9 October 2008

Corneal endothelial cell density and morphology in Phramongkutklao Hospital

Narumon Sopapornamorn, Manapon Lekskul, Suthee Panichkul

Clinical Ophthalmology 2008, 2:147-151

Published Date: 17 March 2008

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis

Peter J Little, Mandy L. Ballinger, Narin Osman

Vascular Health and Risk Management 2007, 3:117-124

Published Date: 18 May 2007

Letter: NEURON – a network of European funding organizations ||FREE PAPER||

Marlies Dorlöchter and Hella Lichtenberg

Neuropsychiatric Disease and Treatment 2005, 1:87-88

Published Date: 9 May 2005